GENEVA, April 8 -- SOUND PHARMACEUTICALS INC. (4010 Stone Way N, Suite 120Seattle, Washington 98103) filed a patent application (PCT/US2025/048505) for "COCHLEAR IMPLANT ELUTING EBSELEN FOR TREATING HEARING LOSS" on Sep 29, 2025. With publication no. WO/2026/073143, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KIL, Jonathan (c/o Sound Pharmaceuticals Inc.4010 Stone Way N, Suite 120Seattle, Washington 98103)
Abstract: Systems and methods of reducing low frequency hearing loss or preserving low-frequency hearing using a...